Role of EPO and TCF7L2 Gene Polymorphism Contribution to the Occurrence of Diabetic Retinopathy

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Rs number</td><td class="align_center">Probe sequences</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">rs551238</td><td class="align_center">CACCTTATTGACCAGCGTAGGCAGA-FAM-</td></tr><tr><td class="align_left">rs1617640</td><td class="align_center">GAGTGAGATTCCCAGAGCAGGAGACTTT-FAM-</td></tr><tr><td class="align_left">rs7903146</td><td class="align_center">TATATAATTTAATTGCCGTATGAGGCACTTT-FAM-</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Probe sequences of the EPO and TCF7L genes.</div>

Disease Markers

tab2

Table 2

Table 2: Role of EPO and TCF7L2 Gene Polymorphism Contribution to the Occurrence of Diabetic Retinopathy 